
| Stock |
Weight |
Amount |
| Gilead Sciences |
14.39% |
$47,592,796 |
| Amgen |
13.40% |
$44,320,559 |
| Biogen Idec |
9.32% |
$30,818,520 |
| Celgene |
8.76% |
$28,988,942 |
| Vertex Pharm |
5.96% |
$19,704,731 |
| Regeneron Pharmaceuticals |
5.54% |
$18,329,264 |
| Life Technologie |
4.72% |
$15,599,108 |
| Illumina |
4.56% |
$15,080,987 |
| Alexion Pharmaceuticals |
4.52% |
$14,944,297 |
| Biomarin Pharmaceutical |
4.07% |
$13,466,468 |
| Onyx Pharmaceuticals |
3.64% |
$12,027,613 |
| Pharmacyclics |
2.53% |
$8,354,423 |
| Qiagen N.V. |
2.31% |
$7,624,966 |
| Cubist Pharmaceuticals |
1.89% |
$6,260,107 |
| Medivation |
1.88% |
$6,225,663 |
| Seattle Genetics |
1.86% |
$6,147,835 |
| Ariad Pharmaceuticals |
1.85% |
$6,120,019 |
| United Therapeutics |
1.56% |
$5,155,449 |
| Incyte |
1.42% |
$4,687,202 |
| Myriad Genetics |
1.35% |
$4,461,143 |
| Page 1 2 next » |
|